Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Iron and Improved Iron Levels

Research synthesisModerate evidenceModerate effect5 studies · 4 beneficial · 0 neutral · 1 harmful

Across 5 studies, 4 reported beneficial moderate-sized effects of iron supplementation on iron levels, while 1 reported a harmful moderate-sized effect in vitiligo patients. The most-studied dose range was 7-105 mg/day elemental iron (from one meta-analysis). Populations varied, including healthy blood donors, pregnant women, and clinical populations (celiac disease, pulmonary hypertension).

  • Studied populations: Healthy blood donors, pregnant women, and clinical populations (celiac disease, pulmonary hypertension); one study in vitiligo patients showed harm.

Caveats: One meta-analysis in vitiligo patients found higher serum iron levels associated with vitiligo, suggesting potential harm from iron excess in this population. The evidence base is diverse across populations, and the optimal dose is not well-established due to limited reporting. Study durations were not consistently reported.

Generated Jul 14, 2026
Doses used in studies
  • Elemental Iron · mg/day: 7–105 (median 56, IQR 7105) 1 study
  • mg/day: 4.2 (median 4.2, IQR 4.24.2) 1 study
Safety in these studies
5 of 5 papers
Back to top